New Delhi, Aug. 28 -- Symbiotec Pharmalab IPO allotment is all set to be finalised on Friday, 28 August. The mainboard IPO received stellar response from investors, with issue being subscribed over 71.26 times.

Under the 'T+3' listing rule, an IPO is required to be listed on the stock exchanges within three days of the closure of the bidding process. Accordingly, Symbiotic Pharmalab IPO shares are expected to debut on the bourses on September 1, 2026. The IPO allotment is therefore likely to be finalised today, and the announcement regarding the share allotment status could be made at any time.

The public offer witnessed strong investor demand, with the issue being subscribed 71.26 times overall by the close of bidding on Thursday. The ...